Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial. - Lorusso D; Gladieff L; O'Malley DM; Kim JW; Garbaos G; Fagotti A; Gilbert L; Mileshkin L; Quesada S; Hopp E; Lee YJ; Oaknin A; et al. (Lancet (London, England), 2026)